| 08/31/2026 7:00 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/25/2026 9:34 AM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 4:00 PM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/12/2026 11:18 AM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/10/2026 3:02 PM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/10/2026 7:00 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/21/2026 7:30 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/15/2026 7:30 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/07/2026 6:49 AM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 10:55 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/06/2026 10:37 AM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for DRTSW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alpha Tau Medical and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/02/2026 10:45 AM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 5:32 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2026 7:21 AM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 10:34 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/26/2026 7:17 AM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2026 5:45 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/25/2026 3:01 PM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/25/2026 9:16 AM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 3:01 PM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/23/2026 5:12 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/11/2026 7:36 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/04/2026 1:29 PM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 6:28 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/03/2026 7:30 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/01/2026 8:00 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/18/2026 3:30 PM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/11/2026 8:29 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/11/2026 6:00 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/08/2026 8:10 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/08/2026 8:00 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2026 8:00 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/05/2026 8:02 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/04/2026 8:00 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/03/2026 11:15 PM | Alpha Tau Medical (1871321) Filer | Form EFFECT | |
| 04/27/2026 6:59 PM | Alpha Tau Medical (1871321) Filer | Form F-3 Registration statement for securities of certain foreign private issuers | |
| 04/27/2026 8:00 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2026 8:02 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/31/2026 8:15 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/18/2026 5:58 PM | Alpha Tau Medical (1871321) Issuer Levy Raphi (1968095) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:59 PM | Alpha Tau Medical (1871321) Issuer Netser Maya (2043002) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
Here’s the stock symbol I’ve promised (Ad) Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better.
This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. Get the stock name and ticker symbol free of charge today |
| 03/18/2026 6:00 PM | Alon Ruth (1796386) Reporting Alpha Tau Medical (1871321) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:01 PM | Alpha Tau Medical (1871321) Issuer MILCH DAVID MARK (1233803) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:02 PM | Alpha Tau Medical (1871321) Issuer Blumenfeld S Morry (1424202) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:03 PM | Adler Alan (1968054) Reporting Alpha Tau Medical (1871321) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:03 PM | Alpha Tau Medical (1871321) Issuer Sofer Uzi (1968053) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:04 PM | Alpha Tau Medical (1871321) Issuer KIDRON NADAV (1351779) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:04 PM | Alpha Tau Medical (1871321) Issuer Avruch Michael (1968047) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/26/2026 6:28 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 8:01 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/02/2026 7:27 AM | Alpha Tau Medical (1871321) Subject Gat Amnon (1968258) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/29/2026 8:00 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/14/2026 6:52 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 6:35 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/09/2026 5:34 AM | Alpha Tau Medical (1871321) Subject Gat Amnon (1968258) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/09/2026 5:06 AM | Alpha Tau Medical (1871321) Subject Levy Raphi (1968095) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/06/2026 8:02 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/05/2026 8:02 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/18/2025 8:02 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/11/2025 6:03 AM | Alpha Tau Medical (1871321) Subject Gat Amnon (1968258) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/09/2025 8:02 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/04/2025 8:02 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/02/2025 8:02 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/01/2025 5:48 AM | Alpha Tau Medical (1871321) Subject Gat Amnon (1968258) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/20/2025 3:07 PM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/03/2025 5:32 AM | Alpha Tau Medical (1871321) Subject Gat Amnon (1968258) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/21/2025 7:35 AM | Alpha Tau Medical (1871321) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/01/2025 6:54 AM | Alpha Tau Medical (1871321) Subject Gat Amnon (1968258) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |